We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
+0.29%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$16.3B
AUM Growth
-$605M
Cap. Flow
-$575M
Cap. Flow %
-3.52%
Top 10 Hldgs %
31.59%
Holding
665
New
90
Increased
197
Reduced
206
Closed
98

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$135M
2
MRK icon
Merck
MRK
+$129M
3
USB icon
US Bancorp
USB
+$91.3M
4
JNJ icon
Johnson & Johnson
JNJ
+$84.2M
5
ELV icon
Elevance Health
ELV
+$72.1M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$185M
2
AABA
Altaba Inc
AABA
+$138M
3
BABA icon
Alibaba
BABA
+$112M
4
TWX
Time Warner Inc
TWX
+$87.5M
5
HUM icon
Humana
HUM
+$87.1M

Sector Composition

Rank Sector Weight
1 Technology 30.1%
2 Healthcare 18.77%
3 Financials 10.98%
4 Communication Services 9.03%
5 Consumer Discretionary 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
51
PepsiCo
PEP
$195B
$83.2M 0.51%
762,469
+10,300
+1% +$1.17M
KDP icon
52
Keurig Dr Pepper
KDP
$42.3B
$74.3M 0.45%
627,779
+625,200
+24,242% +$69.3M
CMPR icon
53
Cimpress
CMPR
$2.43B
$74.3M 0.45%
480,000
-310,000
-39% -$46.2M
IBKR icon
54
Interactive Brokers
IBKR
$40.5B
$73.1M 0.45%
4,350,176
-1,000,000
-19% -$16.5M
APH icon
55
Amphenol
APH
$177B
$71.6M 0.44%
3,324,592
+308,800
+10% +$6.95M
TDC icon
56
Teradata
TDC
$2.75B
$70.4M 0.43%
1,774,383
+87,500
+5% +$3.45M
BAP icon
57
Credicorp
BAP
$30.9B
$64M 0.39%
282,100
-65,600
-19% -$14.6M
GSK icon
58
GSK
GSK
$108B
$59M 0.36%
1,208,560
+356,800
+42% +$16.6M
NXPI icon
59
NXP Semiconductors
NXPI
$65.4B
$58.5M 0.36%
500,240
-77,932
-13% -$9.4M
CAVM
60
DELISTED
Cavium, Inc.
CAVM
$52.9M 0.32%
666,307
+330,333
+98% +$28.8M
WB icon
61
Weibo
WB
$1.95B
$50M 0.31%
418,660
-182,480
-30% -$23.3M
TWX
62
DELISTED
Time Warner Inc
TWX
$49.2M 0.3%
520,400
-928,184
-64% -$87.5M
HRG
63
DELISTED
HRG Group, Inc.
HRG
$48.5M 0.3%
2,941,762
+789,665
+37% +$13.2M
BRK.B icon
64
Berkshire Hathaway Class B
BRK.B
$1.11T
$47.9M 0.29%
240,000
-20,000
-8% -$4.11M
HUM icon
65
Humana
HUM
$46.7B
$46.1M 0.28%
171,615
-321,636
-65% -$87.1M
AET
66
DELISTED
Aetna Inc
AET
$43.5M 0.27%
257,680
-61,020
-19% -$11M
NBIS
67
Nebius Group N.V.
NBIS
$43.1B
$42.9M 0.26%
1,086,300
-181,400
-14% -$7.12M
CL icon
68
Colgate-Palmolive
CL
$74.2B
$42.8M 0.26%
597,056
+580,159
+3,434% +$41.7M
INXN
69
DELISTED
Interxion Holding N.V.
INXN
$40.4M 0.25%
650,000
-10,000
-2% -$597K
ALLY icon
70
Ally Financial
ALLY
$13.4B
$38.6M 0.24%
1,420,000
-350,000
-20% -$10M
AY
71
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$37.7M 0.23%
1,925,118
-349,200
-15% -$7.09M
ADI icon
72
Analog Devices
ADI
$178B
$37.7M 0.23%
413,200
-161,054
-28% -$14.7M
SHAK icon
73
Shake Shack
SHAK
$2.55B
$37.5M 0.23%
900,000
HPQ icon
74
HP
HPQ
$25.9B
$37.4M 0.23%
1,707,000
-61,200
-3% -$1.38M
MCD icon
75
McDonald's
MCD
$194B
$36.9M 0.23%
236,000
-18,300
-7% -$3.01M

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q1 2018 Portfolio in Review

As of Q1 2018, Grantham, Mayo, Van Otterloo & Co (GMO) held 665 positions worth $16.3B, down 3.6% from $17B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO) withdrew a net $575M in Q1 2018, closing 98 positions and reducing 206 holdings. Its most notable exit was CVS Health, an estimated $75.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Grantham, Mayo, Van Otterloo & Co (GMO) opened a new position in Meta Platforms (Facebook) worth $120M.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q1 2018 buy was Meta Platforms (Facebook): 752,487 shares worth $120M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Merck in Q1 2018, an estimated $129M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q1 2018 reduction was Microsoft, cutting an estimated $185M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited CVS Health in Q1 2018, selling an estimated $75.9M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 32% of its $16.3B portfolio in Q1 2018.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 90 new positions and closed 98 in Q1 2018.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 3.6% quarter-over-quarter to $16.3B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2018, filed 15 May 2018.